| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... Nature 500 (7463), 415-421, 2013 | 9918 | 2013 |
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6218 | 2005 |
| Multicenter validation of a gene expression–based prognostic signature in lymph node–negative primary breast cancer JA Foekens, D Atkins, Y Zhang, FCGJ Sweep, N Harbeck, A Paradiso, ... Journal of Clinical Oncology 24 (11), 1665-1671, 2006 | 438 | 2006 |
| The complexity of targeting EGFR signalling in cancer: from expression to turnover S Sebastian, J Settleman, SJ Reshkin, A Azzariti, A Bellizzi, A Paradiso Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1766 (1), 120-139, 2006 | 396 | 2006 |
| The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin—one single nature S Harguindey, G Orive, JL Pedraz, A Paradiso, SJ Reshkin Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1756 (1), 1-24, 2005 | 340 | 2005 |
| NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space G Busco, RA Cardone, MR Greco, A Bellizzi, M Colella, E Antelmi, ... The FASEB Journal 24 (10), 3903-3915, 2010 | 262 | 2010 |
| Corrigendum: Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, S Aparicio, S Behjati, ... Nature 502 (7470), 258-258, 2013 | 244 | 2013 |
| Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients A Paradiso, G Simone, S Petroni, B Leone, C Vallejo, J Lacava, A Romero, ... British journal of cancer 82 (3), 560-567, 2000 | 221 | 2000 |
| Australian Pancreatic Cancer Genome I LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ... Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …, 2013 | 220 | 2013 |
| Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β‐tubulins S Tommasi, A Mangia, R Lacalamita, A Bellizzi, V Fedele, A Chiriatti, ... International journal of cancer 120 (10), 2078-2085, 2007 | 213 | 2007 |
| Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer A Paradiso, A Mangia, A Chiriatti, S Tommasi, A Zito, A Latorre, F Schittulli, ... Annals of Oncology 16, iv14-iv19, 2005 | 197 | 2005 |
| Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na+/H+ exchange, motility, and invasion induced by serum deprivation SJ Reshkin, A Bellizzi, V Albarani, L Guerra, M Tommasino, A Paradiso, ... Journal of Biological Chemistry 275 (8), 5361-5369, 2000 | 177 | 2000 |
| Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors P Parrella, ML Poeta, AP Gallo, M Prencipe, M Scintu, A Apicella, ... Clinical Cancer Research 10 (16), 5349-5354, 2004 | 172 | 2004 |
| Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer R Divella, A Mazzocca, A Daniele, C Sabbà, A Paradiso International journal of biological sciences 15 (3), 610, 2019 | 171 | 2019 |
| The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy Y Zhang, AM Sieuwerts, M McGreevy, G Casey, T Cufer, A Paradiso, ... Breast cancer research and treatment 116, 303-309, 2009 | 171 | 2009 |
| The NHERF1 PDZ2 domain regulates PKA–RhoA–p38-mediated NHE1 activation and invasion in breast tumor cells RA Cardone, A Bellizzi, G Busco, EJ Weinman, ME Dell'Aquila, ... Molecular biology of the cell 18 (5), 1768-1780, 2007 | 148 | 2007 |
| A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies G Ranieri, CD Gadaleta, R Patruno, N Zizzo, MG Daidone, MG Hansson, ... Critical reviews in oncology/hematology 88 (1), 187-197, 2013 | 139 | 2013 |
| Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines RA Cardone, A Bagorda, A Bellizzi, G Busco, L Guerra, A Paradiso, ... Molecular biology of the cell 16 (7), 3117-3127, 2005 | 135 | 2005 |
| Paclitaxel Induces Apoptosis via Protein Kinase A- and p38 Mitogen-activated Protein-dependent Inhibition of the Na+/H+ Exchanger (NHE) NHE Isoform 1 in … SJ Reshkin, A Bellizzi, RA Cardone, M Tommasino, V Casavola, ... Clinical cancer research 9 (6), 2366-2373, 2003 | 133 | 2003 |
| Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines … A Azzariti, NA Colabufo, F Berardi, L Porcelli, M Niso, GM Simone, ... Molecular cancer therapeutics 5 (7), 1807-1816, 2006 | 131 | 2006 |
